A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...
Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...
In some ways, Ozempic is presented as part of the anti-diet movement, acknowledging that diets don’t work and medication may ...
MyStateline.com on MSN13d
Is ‘microdosing’ Ozempic becoming a trend?One endocrinologist told the Hollywood Reporter that her patients have started asking about microdosing Ozempic as way to ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
Insurance for weight-loss drugs like Ozempic is shaping up as the next power struggle between employers and employees. Some companies have curbed or ended coverage for blockbuster weight-loss ...
A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 among U.S. adults without diabetes. The research, published April 1 in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback